Marketing Communications Ink

Putting Words, Images and Ideas to Work

A Virus That Kills Cancer: The Cure That’s Waiting in the Cold

This image is in the public domain and ...

Virus cell image, courtesy of Wikipedia

Aug. 31, 2o12 – For this, my first entry of “Ripped from the Headlines”, a new section where I plan to drop in interesting, funny, noteworthy or just curious stories I’d read in the news, I was about to drop in an article that appeared in the UK-based Telegraph, regarding a possible breakthrough in creating sperm from a man’s skin cells — interesting in its own right — but inside that article was buried a link to another article, even more fascinating.

The second article by Alexander Masters, titled “A Virus That Kills Cancer: The Cure That’s Waiting in the Cold“, reports that, “Sitting in a refrigerator in a Swedish laboratory is what promises to be a cheap and effective cancer treatment. So why are the trials to bring it to market not going ahead?”

The article quotes Professor Magnus Essand who says that neuroendocrine tumors which are resistant to all other drugs — and which, by the way, killed Steve Jobs — were “melting away” in the laboratory mice treated with his adenovirus therapy. But for lack of funding to continue the study, further research is on hold.

Of course this situation is not unique. Many diseases go untreated for lack of funding. And, more often than not, promising cures that worked fabulously in lab animals, and which took years of work and millions of dollars to develop, fail when tested in humans. Whether the clinical trial outcome of Dr. Essand’s study will be any different, if it ever gets back off the ground, is hard to say.

But, the article was fascinating on many levels, easily understood even if you’re not a scientist, and worth the read.

And, in case you happen to have some spare cash, donations for funding are welcome.

To read the full article, click here.

One comment on “A Virus That Kills Cancer: The Cure That’s Waiting in the Cold

  1. Suzy Kedzierski
    July 6, 2014

    July 2014 Update – I was curious to see if any progress had been made since posting this, two years ago. Good news! Thanks to Alexander Masters’ original story, and his suggestion that Professor Essand start a fund-raising effort, enough funding was raised to fund Phase 1/IIa clinical trials. Baylor College of Medicine (Houston TX) is producing the clinical grade virus (as of Feb. 2014), and the hope is to begin trials later this year. You can read more about their progress (and donate to their fund) at http://www.uu.se/en/support/oncolytic.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

Information

This entry was posted on September 1, 2012 by in Business, Ripped From the Headlines and tagged , .
%d bloggers like this: